Cor Vasa 2014, 56(4):475-476

Je změna dosažená v testu šestiminutovou chůzí prediktorem dlouhodobé prognózy pacientů s plicní arteriální hypertenzí?

Doc. MUDr. Martin Hutyra, Ph.D.
I. interní klinika - kardiologická, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc

Published: August 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hutyra M. Je změna dosažená v testu šestiminutovou chůzí prediktorem dlouhodobé prognózy pacientů s plicní arteriální hypertenzí? Cor Vasa. 2014;56(4):475-476.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. N. Galiè, M.M. Hoeper, M. Humbert, et al., Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT), European Heart Journal 30 (2009) 2493-2537.
    2. R.L. Benza, D.P. Miller, M. Gomberg-Maitland, et al., Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL), Circulation 122 (2010) 164-172. Go to original source... Go to PubMed...
    3. M. Humbert, O. Sitbon, A. Chaouat, et al., Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era, Circulation 122 (2010) 156-163. Go to original source... Go to PubMed...
    4. S. Rich, The 6-minute walk test as a primary endpoint in clinical trials for pulmonary hypertension, Journal of the American College of Cardiology 60 (2012) 1202-1203. Go to original source... Go to PubMed...
    5. J.S. Fritz, C. Blair, R.J. Oudiz, et al., Baseline and follow-up six minute walk distance and BNP predict 2-year mortality in pulmonary arterial hypertension, Chest 143 (2013) 315-323. Go to original source... Go to PubMed...
    6. N.B. Gabler, B. French, B.L. Strom, et al., Validation of six-minute-walk distance as a surrogate endpoint in pulmonary arterial hypertension trials, Circulation 126 (2012) 349-356. Go to original source... Go to PubMed...
    7. G. Savarese, S. Paolillo, P. Costanzo, et al., Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension?: a meta-analysis of 22 randomized trials, Journal of the American College of Cardiology 60 (2012) 1192-1201. Go to original source... Go to PubMed...
    8. M. Gomberg-Maitland, T.M. Bull, R. Saggar, New trial designs and potential therapies for pulmonary arterial hypertension, Journal of the American College of Cardiology 62 (2013) D82-D91. Go to original source... Go to PubMed...
    9. T. Pulido, I. Adzerikho, R. Channick, et al., Macitentan and morbidity and mortality in pulmonary arterial hypertension, New England Journal of Medicine 369 (2013) 809-818. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes